Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hematologic Malignancies
•
Melanoma/Skin Cancer
•
Dermatology
Should JAK inhibitors be avoided in patients with a recent history of melanoma?
Related Questions
How would you approach management of a large, fungating squamous cell carcinoma of the auricle if surgical management is not desired by the patient?
Is there a general consensus on margins to use when treating SCCIS or BCC with ED&C?
Would you consider proceeding with a sentinel lymph node biopsy after wide excision revealed 1.2 mm residual non-ulcerated T2a melanoma on the upper back?
What biologics would you use in a patient with rheumatoid arthritis who developed multiple basal cell carcinomas requiring Mohs surgery while on a TNF-inhibitor and did not respond to rituximab?
In what circumstances would you recommend adjuvant radiation for a keratocanthoma with SCC after resection?
How do you manage new-onset vitiligo in a patient on immune checkpoint inhibitors?
How have you used Hedgehog pathway inhibitors as neoadjuvant/adjuvant therapies?
Is rechallenge with nivolumab appropriate after a non–SJS EM-like vesicobullous eruption with limited mucosal disease?
Is there a role for resection of the cutaneous primary in a patient on dual-agent immunotherapy for metastatic melanoma?
How would you approach the radiation treatment of multiple recurrent lentigo maligna on the sole of the foot in an active patient not desiring further surgery?
